Cargando…

Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy

INTRODUCTION: The increasing age, higher modifiable and inherent cardiovascular disease (CVD) risk of HIV-infected patients [1] necessitates improved approaches to reducing co-morbidities. We aimed to assess the effectiveness of a team intervention in reducing modifiable CVD risk. MATERIALS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloch, Mark, Jayewardene, Avindra, Vincent, Trina, Linton, Natalie, Quan, Dick, Gowers, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224784/
https://www.ncbi.nlm.nih.gov/pubmed/25394053
http://dx.doi.org/10.7448/IAS.17.4.19546
_version_ 1782343403580686336
author Bloch, Mark
Jayewardene, Avindra
Vincent, Trina
Linton, Natalie
Quan, Dick
Gowers, Andrew
author_facet Bloch, Mark
Jayewardene, Avindra
Vincent, Trina
Linton, Natalie
Quan, Dick
Gowers, Andrew
author_sort Bloch, Mark
collection PubMed
description INTRODUCTION: The increasing age, higher modifiable and inherent cardiovascular disease (CVD) risk of HIV-infected patients [1] necessitates improved approaches to reducing co-morbidities. We aimed to assess the effectiveness of a team intervention in reducing modifiable CVD risk. MATERIALS AND METHODS: HIV-infected patients ≥50 years attending a large HIV caseload primary-care practice, who were virologically suppressed on antiretroviral therapy (ART), with moderate or severe 10-year CVD Framingham risk (≥10%) were recruited for this prospective case-control study. Intervention participants were provided a team approach to care, which involved treatment by study doctors for lipid, hypertension and ART management, and monthly review by a team of research nurses and dieticians for smoking cessation, exercise and dietary advice over 12 months. Controls were matched on age and smoking status, and were given standard of care (SOC) by non-study doctors. Outcomes included CVD risk factors, body composition and CVD risk assessment, including Framingham 10-yr risk [2] and D:A:D 5-year estimated risk of coronary heart disease (CHD) [3]. Repeated measures analysis of variance was used to examine pre- and post-intervention differences, with p-values used to assess time and main effects of approach to care (Intervention, SOC). RESULTS: A total of 33 patients completed the intervention, with 33 controls (58.0±6.8 and 59.1±6.9 years, respectively). Smoking cessation occurred in 25% cases versus nil controls. There was a significant change in CVD risk between intervention and control groups, in both Framingham scores (time and group×time interaction) and D:A:D scores (group×time interaction only) (Table 1). There was also a significant difference in change in total cholesterol over the study period (time and group×time interaction). Body composition was only measured in intervention patients, with a significant loss in % body fat observed in pre- and post-intervention. CONCLUSIONS: Team intervention was significantly more effective than standard of care in reducing CVD risk in HIV-infected patients on ART. A team approach to care may be an important component of reducing CVD risk in this population.
format Online
Article
Text
id pubmed-4224784
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-42247842014-11-13 Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy Bloch, Mark Jayewardene, Avindra Vincent, Trina Linton, Natalie Quan, Dick Gowers, Andrew J Int AIDS Soc Poster Sessions – Abstract P014 INTRODUCTION: The increasing age, higher modifiable and inherent cardiovascular disease (CVD) risk of HIV-infected patients [1] necessitates improved approaches to reducing co-morbidities. We aimed to assess the effectiveness of a team intervention in reducing modifiable CVD risk. MATERIALS AND METHODS: HIV-infected patients ≥50 years attending a large HIV caseload primary-care practice, who were virologically suppressed on antiretroviral therapy (ART), with moderate or severe 10-year CVD Framingham risk (≥10%) were recruited for this prospective case-control study. Intervention participants were provided a team approach to care, which involved treatment by study doctors for lipid, hypertension and ART management, and monthly review by a team of research nurses and dieticians for smoking cessation, exercise and dietary advice over 12 months. Controls were matched on age and smoking status, and were given standard of care (SOC) by non-study doctors. Outcomes included CVD risk factors, body composition and CVD risk assessment, including Framingham 10-yr risk [2] and D:A:D 5-year estimated risk of coronary heart disease (CHD) [3]. Repeated measures analysis of variance was used to examine pre- and post-intervention differences, with p-values used to assess time and main effects of approach to care (Intervention, SOC). RESULTS: A total of 33 patients completed the intervention, with 33 controls (58.0±6.8 and 59.1±6.9 years, respectively). Smoking cessation occurred in 25% cases versus nil controls. There was a significant change in CVD risk between intervention and control groups, in both Framingham scores (time and group×time interaction) and D:A:D scores (group×time interaction only) (Table 1). There was also a significant difference in change in total cholesterol over the study period (time and group×time interaction). Body composition was only measured in intervention patients, with a significant loss in % body fat observed in pre- and post-intervention. CONCLUSIONS: Team intervention was significantly more effective than standard of care in reducing CVD risk in HIV-infected patients on ART. A team approach to care may be an important component of reducing CVD risk in this population. International AIDS Society 2014-11-02 /pmc/articles/PMC4224784/ /pubmed/25394053 http://dx.doi.org/10.7448/IAS.17.4.19546 Text en © 2014 Bloch M et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Sessions – Abstract P014
Bloch, Mark
Jayewardene, Avindra
Vincent, Trina
Linton, Natalie
Quan, Dick
Gowers, Andrew
Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title_full Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title_fullStr Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title_full_unstemmed Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title_short Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
title_sort effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in hiv-infected subjects on antiretroviral therapy
topic Poster Sessions – Abstract P014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224784/
https://www.ncbi.nlm.nih.gov/pubmed/25394053
http://dx.doi.org/10.7448/IAS.17.4.19546
work_keys_str_mv AT blochmark effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy
AT jayewardeneavindra effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy
AT vincenttrina effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy
AT lintonnatalie effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy
AT quandick effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy
AT gowersandrew effectivenessofateaminterventioninreducingmodifiablecardiovasculardiseaseriskinhivinfectedsubjectsonantiretroviraltherapy